dihexa fda approval status 2026 Dihexa: Off Category 2, But Is It Legit? (2026) Dihexa Capsules 10mg (30ct) |

As a synaptogenic peptide, Dihexa represents a new category of interventionnot just slowing decline, but potentially reversing it

Most experienced users recommend starting conservatively and titrating upward based on individual response

Method of Administration : BPC 157 can be taken either systemically (e.g., injecting subcutaneously a few inches from the belly button) or locally (injecting directly at or near the site of injury)

The most commonly reported side effects in clinical trials include: Nausea Vomiting Diarrhea Constipation Most of these symptoms were mild to moderate and tended to improve over time as the body adjusted to the medication, especially when doses were increased gradually

Lower Barrier to Entry: Oral peptides allow individuals to explore tissue support supplementation without committing to injection protocols, making it appropriate for peptide therapy beginners